Results 241 to 250 of about 105,968 (369)
ABSTRACT Background and Aims We investigated the associations between SLD, fibrosis stage, and all‐cause and cause‐specific mortality, with a focus on SLD subtypes. Methods We analysed 486 156 UK Biobank participants. SLD cases were identified using fatty liver index ≥ 60. Causes of death were confirmed via death registries.
Qi Feng +5 more
wiley +1 more source
The effect of hepatic steatosis index on prediabetes: A large-scale retrospective cohort study. [PDF]
Huang X +5 more
europepmc +1 more source
Opposite kinetics of L-leucine and L-phenylalanine induced insulin release studies with the perfused rat pancreas [PDF]
Landgraf, R. +3 more
core
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao +2 more
wiley +1 more source
Pathobiology of Prediabetes: Understanding and Interrupting Progressive Dysglycemia and Associated Complications. [PDF]
Dagogo-Jack S.
europepmc +1 more source
Abstract INTRODUCTION Metabolic dysfunction–associated steatotic liver disease (MASLD) has been linked to adverse brain outcomes. We aim to evaluate whether MASLD is associated with cognitive impairment/decline. METHODS We analyzed data from the Estudo Longitudinal da Saúde do Adulto (ELSA‐Brasil study).
Raphael Machado Castilhos +4 more
wiley +1 more source
A comparative analysis of anthropometric indices for identifying prediabetes in US adults: results from NHANES 2021-2023. [PDF]
Chen X, Yan L, Yang J, Yang S.
europepmc +1 more source
Efficacy and Safety of Berberine for Prediabetes: A Systematic Evaluation and Meta-Analysis
Li Wang +3 more
openalex +2 more sources

